Category: CannabisNewsWire Release

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Acquisition Agreement with German-Based Pharmaceutical, Medical Cannabis Distributor

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a definitive agreement with Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry. The agreement outlines Flora Growth’s plans to acquire 100% of Franchise Global Health, which has principal operations in Germany, in an all-stock transaction. According to the agreement, the acquisition gives FLGC a foothold in German’s medical cannabis space because FGH’s German businesses service an estimated 1,200 pharmacies in the country; FGH also provides noncannabis medical products to 28 additional countries. In the first six months of this year, FGH reported revenue of approximately C$30.1 million; total aggregated reported revenues for both companies for the period ended June 30, 2022, reached $38.6 million. The agreement calls for Flora Growth’s indirect acquisition of FGH’s subsidiaries, including Phatebo GmbH, a leading distributor of export pharmaceuticals and medical cannabis products to the European Union, and ACA Müller ADAG Pharma Vertriebs GmbH, which holds the first German medical cannabis import and distribution license ever granted. “Through this proposed acquisition, we are connecting our commercial infrastructure and medical cannabis product portfolio to the German and EU medical markets, while gaining direct access to European pharmaceutical distributions,” said Flora Growth chair and CEO Luis Merchan in the press release. “We believe Franchise will significantly increase our commercial international revenue and provide essential distribution to German pharmacies and a growing wholesale market.”

To view the full press release, visit https://cnw.fm/Hjoj7

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) Leaders Talk Game-Changing Microfarm Growing Option on Episode of Leading Podcast

  • ACTX CEO Doug Heldoorn, Grow Pod inventor Shannon Illingworth discuss the innovative microfarm option on recent Gamechangers LIVE podcast
  • Discussion focuses on history of company, significant health and safety benefits of Grow Pods
  • Company is dedicated to developing, manufacturing and selling advanced cultivation equipment and packaging systems

Advanced Container Technologies (OTC: ACTX) chair and CEO Doug Heldoorn was a featured guest on a recent episode of the Gamechangers LIVE podcast (https://cnw.fm/3xv5t). Heldoorn was joined by Shannon Illingworth, inventor of Grow Pods, the microfarm containers that ACTX distributes throughout the United States. During the podcast, the two men discussed the origins of Advanced Container Technologies and its potential to change the future of farming  (https://cnw.fm/Ip42j).

“When I was speaking with Shannon — I’ve known him for 15 years — we were all in the same space,” said Heldoorn during the interview. “He was talking about growing these organic superfoods. It all flowed together, which was pretty cool. . . . There was an opportunity to merge and get our brains together working toward a common goal of what’s missing in society right now.

“One [Grow Pod] will grow an acre of food with a third of the water it takes [for traditional farming] and less space, with no metals or toxins,” he continued. “Everybody right now is right on that bandwagon of doing things healthier and more responsible to the environment. We really think we’re on to something that’s going to be incredible.”

Advanced Container Technologies is dedicated to developing, manufacturing and selling advanced cultivation equipment, proprietary packaging systems, and a variety of other products to help businesses and entrepreneurs enter or expand in the rapidly growing cannabis and hemp markets. One of the company’s main business units is focused on selling Grow Pods, which are advanced, self-contained hydroponic containers. These innovative automated systems are essentially microfarms that can be placed virtually anywhere and, with its controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year.

“The good thing about the [Grow Pods] container is that it can give traditional farmers a niche where they can grow year-round versus three or four times per year,” said Illingworth. “We can really revolutionize what’s going on in our society. People don’t realize that we get the majority of our produce through just two states – Arizona and California. By the time [food] gets across state lines, it’s already stale. . . . We give the ability to be farm to table. . . . There’s no reason why every state can’t be agriculture independent and growing year-round.”

The Gamechangers LIVE podcast was hosted by executive coach Sergio Tigera; the podcast series is designed to shine the spotlight on individuals who are gamechangers in their fields and provide a venue for them to share perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor micro-farms called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R) that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

Click here to view the Gamechangers LIVE podcast.

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Data Shows That Less Than 10% of Canadian Marijuana Licensees Exited Growing Industry

New data from the Canadian government shows that less than 10% of federal marijuana license holders have left the market since the plant was legalized in 2018. This data suggests that industry forecasts of a decrease in marijuana producers in the market has not occurred, as new entries into the hypercompetitive market surpass those exiting by a wide margin.

The new data was released as part of the Canadian government’s engagement paper for the Cannabis Act review. The public engagement paper also asks questions relevant to the industry to help gather feedback; that feedback will be used by the government to inform the legislative review of the law.

Since October 2018, about 95 marijuana license holders left the burgeoning industry. Of this number, 67 held standard licenses, which face no canopy limits; 13 held licenses for sale for medical purposes only; and the remaining were micro-license holders.

The data doesn’t delve into why the licensees left the market. However, industry experts believe that marijuana businesses suffer from overtaxation, which makes it hard to operate in the increasingly competitive market. In this environment, businesses often have to restructure or find new investors to help them compete, which is easier said than done. At the moment, Canada has only 920 active federal marijuana licenses.

An analysis of the data also shows that the most profitable marijuana businesses in the country are government owned while profits generated from the private sector are uncommon. In addition, the data showed that cultivators in the country produced roughly 618 tons of dried marijuana last fall, which brought the total amount stored by licensed retailers, wholesalers and producers to 1.4 billion grams.

It also showed that about 43% of dried marijuana production in the country in the period between October 2019 and December 2021 was generated by 10 standard license holders. In comparison, less than 1% of all marijuana production in the country was generated from 178 holders of micro-licenses.

These numbers come as the country’s legal market grows and displaces the illegal market. The recently released data also demonstrated that by the fourth quarter of 2021, legal marijuana sales were two times higher than sales in the illicit market.

In figures, combined recreational and medical marijuana sales in legal channels hit C$1.3 billion during the fourth quarter of 2021 while sales in the illegal market declined to C$660 million during the same period. The Canadian government remains committed to combating the illicit market by providing consumers with the ability to purchase marijuana from regulated and legal sources.

It would interesting to see a similar attrition analysis done for the different marijuana markets within the United States, including jurisdictions where established actors such as Advanced Container Technologies Inc. (OTC: ACTX) operate alongside mainstream marijuana companies.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How President Biden’s Marijuana Directives Could Affect the Industry

After about 50 years of legally sanctioned prohibition in the United States, marijuana has reached a pivotal moment that could rewrite the industry as it currently stands. Earlier this month, President Joe Biden directed the relevant federal agencies to conduct an exhaustive review into the scheduling of cannabis in the Controlled Substances Act. That directive has set in motion a process that could end in one of an endless list of possible outcomes, and only the most foolhardy of “analysts” can authoritatively predict what the outcome will be.

For example, the review process could recommend a continuation of the status quo, that is, marijuana remains in Schedule 1 of the CSA. However, as the president himself commented, this doesn’t make sense. For instance, there is no currently documented lethal dose of marijuana because no fatality can at the moment be linked to an overconsumption of marijuana.

However, the very categorization of cannabis as a Schedule 1 drug means that there will be a big mountain to climb for marijuana to be removed from this strictest categorization because cannabis research is in its relative infancy. In the highly likely event that it is removed, the big question would be: Where does it go? Schedule 2, also highly restricted but with the proviso that substances in this group can be used under medical supervision, would be the worst possible review process outcome for marijuana.

This is because any marijuana product that is sanctioned to go to market would have to pass the rigorous FDA approval process, and then it wouldn’t be sold for recreational use because Schedule 2 drugs are medicines that can only be accessed by prescription. In short, this would be like a death blow to the legal marijuana industry as we currently know it.

There are six schedules in the CSA, and the ideal outcome for the marijuana industry would be for the substance not to appear in any of those categories. The reason for this is because a measure of FDA oversight is mandated in each category, and FDA processes aren’t exactly what the medical or marijuana industries are built for. The desired tax relief can come via putting marijuana in Schedules 3 or 4, but that would be little comfort because at those levels, products would only be available under doctors’ orders.

The best scenario is for Congress to pass a law decriminalizing marijuana and granting states permission to decide for themselves how to regulate this now federally decriminalized substance. Such a law can render null and void any policy change resulting from the review process triggered by Biden’s orders.

As things stand, there is no telling where this review process will lead, and Biden may have unknowingly kick-started a process that could accelerate the path to marijuana legalization or make life for the existing auxiliary industry players such as REZYFi Inc. harder as more onerous federal rules affecting how companies serving the marijuana industry are required to report their dealings to federal regulators.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Holds Potential to Represent Multiple Commercial Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria believed, could have significant commercial potential considering that many antiviral drugs typically show low oral bioavailability in their available form because of significant liver biotransformation and/or poor intestinal uptake,” reads a recent article. “Lexaria’s vision for DehydraTECH is not limited to antiviral drugs as the company is also focusing on other possible mainstream applications of its disruptive drug delivery platform, including but not limited to oral nicotine and cannabidiol (‘CBD’). Pharmacokinetic studies evaluating these compounds have, in fact, shown that DehydraTECH delivers higher quantities of these APIs in less time… DehydraTECH’s ability to increase the performance of different APIs represents multiple commercial opportunities that, when tapped, could potentially address serious unmet patient needs.”

To view the full article, visit https://cnw.fm/8Mnlp

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Senator Believes Marijuana Reforms Can Still Be Passed During Lame-Duck Congressional Session

Senator Cory Booker has revealed that there is a chance that some marijuana policy reforms, such as social justice and cannabis banking reforms, can still be approved by Congress during the session coming just after the November elections and before a new House takes office. He was quick to add that such an opportunity may be harder to get in case Republicans wrest control of either the House of Representatives or Senate out of the control of the Democrats.

The senator made these remarks during an interview with a New Jersey-based media outlet called NJ.com. Booker said that Congressional leadership was conducting active negotiations regarding a series of marijuana policy change proposals before the recess paving way for midterm elections starts.

Booker was confident that during the sittings, often called lame-duck sessions, there is a high possibility that bipartisan support will galvanize into action in favor of passing reform before a new Congress takes office. This is because supporters on both sides of the political aisle are aware that passing cannabis reforms is likely to become harder once the elections bring changes to the dominant party in either legislative chamber.

In the interview, Booker expressed frustration that the legalization of cannabis at state level hasn’t yielded the democratizing effect hoped for in the industry. He cited the small number of minority-owned cannabis companies in New Jersey as an example of the lack of equity in this nascent industry. He added that there was an urgent need for the U.S. Senate to take steps and enact reforms that catered to different issues, such as bringing accessibility to the banking system, implementing restorative justice and channeling tax dollars into creating employment opportunities as well as combating the wave of addiction sweeping across the country.

Regarding President Joseph Biden’s recent directives on marijuana, Booker expressed happiness about the decisions and said that those decisions were a fulfillment of several out-of-camera discussions he and the president had had back when President Biden was campaigning for the top office in the land. While Booker was initially opposed to passing any cannabis banking reforms before comprehensive social justice changes are made, the legislator eventually signaled a change of heart and indicated that he could consider supporting banking reform if some social justice provisions were added to the initiative.

The cannabis industry and entities such as Flora Growth Corp. (NASDAQ: FLGC) await any changes that may come out of Capitol Hill during the lame-duck session and beyond. Hopefully, those changes bring the long-awaited policy reforms that can enable the industry to grow while addressing concerns about public health and access by minors.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Michigan Hits New Marijuana Sales Record in September

New data from the state of Michigan shows that for the third time this year, the state has broken a new record in its cannabis sales. Sales data from September shows that the state raked in $212 million from both medical and adult-use marijuana sales. This figure is $17 million higher than the state’s April sales and roughly $2 million higher than the state’s July sales.

The data shows that the majority of the cannabis purchases for both recreational and medical use were for flower products. It also demonstrated a continuation of a sales trend in the state’s cannabis market, with adult-use sales for cannabis increasing while medical marijuana purchases continue to decline.

The state’s first recreational cannabis shops launched in December 2019.

This new data comes after regulators in the state announced that they would be issuing grants to support studies into the therapeutic benefits of cannabis for veterans, using tax revenues generated from adult-use marijuana sales. The Cannabis Regulatory Agency also revealed that it had recommended awarded grants worth $20 million to a pair of universities as part of the Veteran Marijuana Research Grant Program.

This comes after officials in the state had announced earlier this year that Michigan would be distributing almost $150 million in cannabis tax dollars, divided between public schools, localities and a transportation fund. The state’s Department of Treasury reported that the funding, which was made possible from tax dollars generated from its adult-use marijuana program, included about $42 million for 53 counties, 33 townships, 15 villages and 62 cities. This figure more than quadruples the amount in funding that the state allocated to municipalities from marijuana tax revenues in 2021.

Cumulatively, the state of Michigan recorded $481,225,540 and $1,311,951,737 in cannabis sales for medical and adult-use cannabis sales in 2021. In December 2021, the state recorded roughly $33 million in medical cannabis sales and more than $135 million in recreational marijuana purchases.

Earlier this year, state regulators also announced the approval of the first-ever social consumption site for adult-use cannabis in Michigan. The site will be located in Hazel Park. In addition, it is expected that as the state’s cannabis industry grows, even more tax dollars will be generated.

Additionally, legislators in the City Council of Hazel Park also approved a measure that designated September as the month of awareness of the therapeutic potential of psychedelics. This comes after the city locally decriminalized entheogenic fungi and plants.

Michigan is on course to become similar to major U.S. marijuana markets such as California where companies such as Prime Harvest Inc. operate and make a contribution to the local economy.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New York Legislator Calls for Research on Determining Marijuana Impairment

As New York State works feverishly to ensure that recreational sales of marijuana are launched on schedule, a leading lawmaker, Crystal Peoples-Stokes, is concerned that at the moment, there is no surefire way to ascertain that someone has consumed marijuana and is impaired.

Peoples-Stokes is the majority leader in the state assembly, and she was pivotal in getting the legalization law passed. She revealed that concerns about finding ways to determine impairment was part of the reason why the bill (now law) had provisions stipulating that 20–25% of the tax revenue generated from recreational marijuana sales should go toward conducting cannabis studies, including on matters such as assessing motorists to confirm whether they are impaired behind the wheel.

She wants leading academic institutions in the state, such as the University of Buffalo, to become actively involved in conducting marijuana research not just on testing for impairment but also on other vital matters such as other beneficial effects that the compounds in this plant can have.

The need for such studies has been impressed upon politicians, advocates and members of the academia by recent reports of an uptick in fatal crashes in some states that have recently legalized adult-use recreational cannabis. Such fatalities are being attributed by some people to people driving while impaired by marijuana, and there is no way to definitively confirm or rule out such claims.

In New York State in 2019, a man in Tonawanda was convicted for committing vehicular manslaughter. This was after the man drove while intoxicated with marijuana and rammed into a retirement home, causing the death of a woman who was inside her apartment in that community.

Are such reports due to isolated incidents or a growing pattern as marijuana use becomes more widespread? Only a scientifically validated test can determine whether those incidents can be directly linked to marijuana legalization in different jurisdictions or whether their prevalence isn’t so high that consumer education on responsible cannabis use cannot tame the possible irresponsible behavior of some marijuana users on the road.

In California, teams of researchers are focused on developing breathalyzers designed identify motorists who may be under the influence of marijuana. However, there is no consensus that there is a link between the amount of THC detectable in someone’s blood, saliva or breath and whether such a person can be described as impaired. Some police authorities have opted to train their personnel to look out for actual signs of impairment in drivers, such as red eyes and delayed reaction time.

Now that New York has also legalized marijuana home grows for patients with a medical marijuana card, an additional client base is likely to open up for companies such as Advanced Container Technologies Inc. (OTC: ACTX) that sell equipment which can help growers harvest high-quality produce indoors.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Nationwide Survey Data Shows Majority of Americans Support Cannabis Policy Reform

We have seen interest in cannabis increase these last few years, with new survey data showing that some three of four Americans, including majorities of Democrats, Republicans and Independents, are in favor of changing marijuana’s classification under federal law. Currently, 37 states and the District of Columbia  have legalized the medical use of marijuana while 19 states have legalized its recreational use.

Despite this, cannabis remains classified under Schedule I of the federal Controlled Substances Act with harmful drugs such as heroin. Drugs under this categorization have no currently accepted medical use in treatment and are thought to have a high potential of abuse. This doesn’t apply to cannabis, which offers a range of benefits, as numerous studies have shown.

Organizations advocating for the reform of cannabis laws, including NORML, have long called for marijuana to be rescheduled to Schedule II or III of the Controlled Substances Act. In a position statement, the organization stated that the descheduling of marijuana would help sort out the conflict that currently exists over cannabis policy at the state and federal level. NORML further asserts that this would also help maintain the market controls that numerous states have enacted to ensure safe business practices, prevent cannabis distribution to minors, promote public health and improve public safety.

Survey findings also show that support from the public to pardon or release individuals convicted for low-level, cannabis-related crimes at the federal or state level is higher from Democrats and Independents, with only a minority of GOP members supporting such efforts.

Nearly a fortnight ago, President Joseph Biden announced that individuals with cannabis-related federal convictions on their records would be pardoned. This would impact a total of about 6,500 individuals because most of these arrests and convictions are made at the local and state levels. In his announcement, the president urged governors to take similar steps then directed that a review on whether cannabis could be classified as a less serious drug be carried out.

Separate poll data also shows that about 44% of voters believe that passing a bill to legalize cannabis at the federal level should be a top or important priority for Congress.

Archived FBI data shows that since the 1960s, roughly 29 million individuals have been arrested for violating local or state cannabis laws. Given that people of color have been disproportionately affected by the war on drugs, the federal legalization of marijuana will be the first step to rectifying these grave wrongs.

As pressure from the grassroots mounts to see cannabis policies reformed federally, a time may soon come when established entities such as American Cannabis Partners will no longer have to contend with contradictions between federal marijuana laws and those at state level.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – REZYFi Inc.’s Diversified Approach Positions It to Capitalize on Growth Across Multiple Verticals

REZYFi, a mortgage lender company servicing the needs of both traditional and non-traditional consumers and businesses, is positioned to be one of the first cannabis mortgage bankers in the United States. In this industry, many traditional lenders are reticent to serve the state-licensed cannabis sector. “REZYFi operates through two wholly owned subsidiaries: REZYFi Lending and ResMac Inc. Leveraging a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA and VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages, REZYFi Lending expects increased funding in marketing and loan agents to drive origination growth over the next two years, which is supported by its planned launch of a high-margin cannabis division later this year. In operation for 13 years, ResMac Inc. allows REZYFi to operate as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations,” reads a recent article. “With its corporate strengths, REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals due to its experience, a network of independent brokers, and proprietary technology.”

To view the full article, visit https://cnw.fm/mGjEQ

About REZYFi Inc.

REZYFi is a cannabis-focused mortgage origination and specialized financing company in the U.S. The company originates, structures and invests in first mortgage loans and alternative structured financings secured by commercial and residential real estate properties. For more information, visit the company’s website at REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.